ZedScan Clinical Trials
Identification and detection of cervical disease
The ability to identify correctly those women who have and those who do not have disease is pivotal to the success of any screening programme. Prevention of cervical cancer depends on colposcopic detection and treatment of high-grade cervical intra-epithelial neoplasia (CIN 2+) in women referred with abnormal cytology.
A number of clinical studies have been completed to assess the performance of an EIS based diagnostic device in the diagnosis of cervical intraepithelial neoplasia (CIN) – Table 1.
|British Journal of Obstetrics and Gynaecology, (March, 2013)*||429|
|Gynecological Oncology, (2009)||104|
|International Journal of Gynecological Cancer, (2006)||176|
|British Journal of Obstetrics and Gynaecology, (2005)||87|